DuPont Faces Critical Test as Quarterly Results Loom

DuPont de Nemours finds itself at a pivotal moment as the chemical giant prepares to release quarterly earnings against a backdrop of significant corporate transformation and diminished market expectations. With shares hovering near annual lows and analysts delivering sharply divided assessments, today’s financial report could determine the company’s near-term trajectory.

Wall Street anticipates DuPont will report adjusted earnings per share between $0.64 and $1.13 for the third quarter of 2025, reflecting the challenging environment the company currently navigates. The consensus estimate has undergone substantial downward revision, dropping 15.1% within the past month alone.

Revenue projections span from $1.77 to $3.12 billion, incorporating the impact of recent portfolio divestitures and the company’s streamlined Read more...